| Application no. and date | 12782326.8 (espacenet) (Federated) (European Patent Register), 20120228 | | Patent/reg. no. and date | DK/EP 2683242, 20200408 | | Publication date | 20140115 | | Priority no. and date | US 201113041211, 20110304 | | EP pub. no. and date |
EP 2683242 20140115 | | Effective date | | | Applicant/owner | Annovis Bio, Inc., 1055 Westlakes Drive, Suite 300
Berwyn, PA 19312, US | | Applicant ref. no. | P73381DK01 | | Inventor | MACCECCHINI, Maria, 1223 Foxglove Lane
West Chester, PA 19380, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/407 (2006.01) , A61P 25/28 (2006.01) | | Title | EFFEKTIVE MÆNGDER (3AR)-1,3A,8-TRIMETHYL-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL-PHENYLCARBAMAT OG FREMGANGSMÅDER DERAF | | Int. application no. | US2012026984 | | Int. publication no. | WO2012154285 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
